Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 220-230 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 55-60%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 60-65%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
85-90%<br />
Prin ci pal Prod ucts:<br />
KETONAL (antirheumatic non-steroidal;<br />
antirheumatic top i cal)<br />
ORTANOL (antiulcerant)<br />
AMOKSIKLAV (pen i cil lin broad spec trum)<br />
TU LIP (cho les terol/triglyceride reg u lat ing prep a -<br />
ra tion)<br />
AMLOPIN (cal cium an tag o nist plain)<br />
Ther a peu tic Range:<br />
antibacterials sys temic 16%<br />
ant ac ids/antiflatulents/antiulcerants 15%<br />
anti rheu ma tics sys temic 14%<br />
lipid-reg u lat ing/antiatheroma prep a ra tions<br />
11%<br />
anti rheu ma tics top i cal 8%<br />
Lead ing Dose Forms:<br />
coated tab lets 38%<br />
tab lets 20%<br />
cap sules 20%<br />
gels/sols 7%<br />
am poules 4%<br />
NOVARTIS<br />
Full Name: Novartis Po land Sp.z.o.o.<br />
Street Ad dress: Al. Witosa 31, 00-710 War saw<br />
Tel: +48 22 550 8888<br />
Fax: +48 22 550 8700<br />
Home Page: www.novartis.pl<br />
Con tacts (Pharm): Chair man: Jyrki Tapani Sura<br />
Par ent of: Ciba Vi sion, Po land (100%).<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 190-200 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 55-60%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 65-70%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
GLIVEC (antineoplastic other)<br />
EXELON (anti-Alz hei mer prod uct)<br />
FORADIL (B2-stim u lant)<br />
SANDOSTATIN LAR (hor mone hy po tha lamic)<br />
SANDIMMUN NEORAL (immunosuppressive<br />
agent)<br />
Ther a peu tic Range:<br />
antineoplastics 27%<br />
antiasthma and COPD prod ucts 14%<br />
CNS drugs other 9%<br />
immunosuppressive agents 9%<br />
antiepileptics 9%<br />
Lead ing Dose Forms:<br />
coated tab lets 41%<br />
cap sules 29%<br />
tab lets 14%<br />
vi als 8%<br />
liq uids 3%<br />
NOVARTIS CON SUMER HEALTH<br />
Full Name: Novartis Po land Sp. z o.o.<br />
Street Ad dress: ul. Bokserska 66, 02-690 War -<br />
saw<br />
Tel: +48 22 375 7575<br />
Fax: +48 22 375 7577<br />
Home Page: www.novartis.pl<br />
Phar ma ceu ti cal Sales: US$ 60-65 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 55-60%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 75-80%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
80-85%<br />
Prin ci pal Prod ucts:<br />
OTRIVIN (na sal prep a ra tion top i cal)<br />
VOLTAREN (antirheumatic top i cal)<br />
VENORUTON (var i cose ther apy sys temic; var i -<br />
cose ther apy top i cal)<br />
OROFAR (throat prep a ra tion)<br />
PROCTO GLYVENOL (antihemorrhoidal top i cal)<br />
Ther a peu tic Range:<br />
na sal prep a ra tions 23%<br />
antivaricosis/antihemorrhoidal prep a ra tions<br />
18%<br />
cough and cold prep a ra tions 16%<br />
anti rheu ma tics top i cal 12%<br />
throat prep a ra tions 9%<br />
Lead ing Dose Forms:<br />
liq uids 31%<br />
gels/sols 23%<br />
tab lets 13%<br />
pow ders/gran ules 11%<br />
creams 7%<br />
SANDOZ<br />
Full Name: Biochemie GmbH Oddzial w<br />
Warszawie<br />
Street Ad dress: ul.Marconich 9 m 6, 02-954<br />
War saw<br />
Tel: +48 22 642 5610/840 8276<br />
Fax: +48 22 642 1526<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 197
Change language